deltatrials
Completed OBSERVATIONAL NCT00341588

A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen

Sponsor: National Cancer Institute (NCI)

Updated 26 times since 2017 Last updated: Aug 19, 2020 Started: Jan 18, 2002 Primary completion: Oct 1, 2008 Completion: Aug 18, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00341588, this observational or N/A phase trial focuses on Testicular Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 26 times since 2002, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Apr 2018 · 10 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Mar 2019 · 6 months · monthly snapshot~Mar 2019 – ~Jun 2019 · 3 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

26 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Sep 2020 — Jan 2021 [monthly]

    Completed

  5. Aug 2020 — Sep 2020 [monthly]

    Completed

Show 21 earlier versions
  1. Jul 2020 — Aug 2020 [monthly]

    Completed

  2. Jun 2020 — Jul 2020 [monthly]

    Completed

  3. Apr 2020 — Jun 2020 [monthly]

    Completed

  4. Mar 2020 — Apr 2020 [monthly]

    Completed

  5. Feb 2020 — Mar 2020 [monthly]

    Completed

  6. Jan 2020 — Feb 2020 [monthly]

    Completed

  7. Dec 2019 — Jan 2020 [monthly]

    Completed

  8. Nov 2019 — Dec 2019 [monthly]

    Completed

  9. Oct 2019 — Nov 2019 [monthly]

    Completed

  10. Sep 2019 — Oct 2019 [monthly]

    Completed

  11. Aug 2019 — Sep 2019 [monthly]

    Completed

  12. Jul 2019 — Aug 2019 [monthly]

    Completed

  13. Jun 2019 — Jul 2019 [monthly]

    Completed

  14. Mar 2019 — Jun 2019 [monthly]

    Completed

  15. Sep 2018 — Mar 2019 [monthly]

    Completed

  16. Jun 2018 — Sep 2018 [monthly]

    Completed

  17. May 2018 — Jun 2018 [monthly]

    Completed

  18. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  19. Jun 2017 — Apr 2018 [monthly]

    Completed NA

  20. May 2017 — Jun 2017 [monthly]

    Completed NA

  21. Jan 2017 — May 2017 [monthly]

    Completed NA

    First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations